Latest biopsy approach for suspected metastases in patients with breast cancer

Naoki Niikura,Bruno C. Odisio,Yutaka Tokuda,Fraser W. Symmans,Gabriel N. Hortobagyi,Naoto T. Ueno
DOI: https://doi.org/10.1038/nrclinonc.2013.182
IF: 78.8
2013-10-22
Nature Reviews Clinical Oncology
Abstract:Key PointsBiopsies of suspected breast cancer metastases are not always performed in routine clinical practice owing to the cost and invasiveness of the procedurePercutaneous image-guided biopsy is a safe, simple low-cost technique to obtain biopsy material from suspected metastasesBiopsies should be performed to determine oestrogen receptor, progesterone receptor or HER2 status of the lesion, particularly if the status of the primary tumour is unknownDiscordance between biomarker status in primary and secondary tumours can occur; however, standardized protocols might prevent discordance that results from technical errorsIncreasing the numbers of biopsies performed throughout the disease trajectory will provide material for biobanks, aid future research, and might lead to innovative targeted therapies for breast cancer
oncology
What problem does this paper attempt to address?